The US Government, through its aid agency USAID, has announced a grant of an additional USD 3 million to India to mitigate the spread of COVID-19.
In coordination with the Indian government, the USAID is providing these funds to the Partnerships for Affordable Healthcare Access and Longevity (PAHAL) project, an innovative financing platform of IPE Global, USAID said in a statement on Wednesday.
US Ambassador to India, Kenneth Juster, stated: "This additional funding to support India in its continuing efforts to combat COVID-19 is yet another example of the strong and enduring partnership between the United States and India."
To date, the USAID has provided USD 5.9 million to assist India in responding to the COVID-19 outbreak. This assistance will help India slow the spread of COVID-19, provide care for the affected, disseminate essential public health messages to communities, and strengthen case finding and surveillance.
Through the PAHAL project, the USAID will support the National Health Authority to establish a financing facility that can mobilize resources from the private sector to assist over 20,000 health facilities enrolled under Pradhan Mantri Jan Arogya Yojana (PM-JAY), India's health insurance scheme for 500 million poor and vulnerable people.
During the talks on April 04, Prime Minister Narendra Modi and US President Donald Trump had agreed to deploy the full strength of the India-US partnership to combat the coronavirus pandemic.
Early this month, India, at the request of President Donald Trump, had exported 35.82 lakh tablets of hydroxychloroquine to the US along with active pharmaceutical ingredient or API required in the manufacturing of the drug.
Trump had thanked India for its decision to export hydroxychloroquine to fight coronavirus and lauded Prime Minister Modi for his "strong leadership" in helping "not just India, but humty" in this fight.
( With inputs from ANI )